Outcome of Board Meeting held on 14th August, 2026

BOSTON COMMERCE LIMITED (Formerly known as Boston Bio Systems Limited) Registered office: Office No. 11, Krishna Complex, Mahatma Gandhi Bridge, Shreyas Colony, Navrangpura, Ahmedabad, 380009 CIN: L62013GJ1995PLC025476; E-mail: bostonsystem@yahoo.com Website: www.bostonbio.in Date: 14th August, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 531458 | ISIN: INE109B01019 Subject: Outcome of the Board Meeting held on 14th August, 2026 Dear Sir/Madam, Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform you that the Board of Directors of Boston Commerce Limited (“the Company”), at its meeting held today, i.e., Friday, 14th August, 2026, inter alia, considered, approved and/or noted the following matters: 1. Resignation of Mr. Ghanshyam Dhananjay Gavali as Managing Director and Director The Board took note of the resignation tendered by Mr. Ghanshyam Dhananjay Gavali (DIN: 03343352) from the position of Managing Director and Director of the Company, with effect from the close of business hours on 12th August, 2026, due to personal commitments. The Board placed on record its appreciation for the valuable contribution and services rendered by Mr. Ghanshyam Dhananjay Gavali during his tenure with the Company. 2. Resignation of Mr. Kunjan Nathabhai Rathod as Chief Financial Officer The Board took note of the resignation tendered by Mr. Kunjan Nathabhai Rathod from the position of Chief Financial Officer (CFO) and Key Managerial Personnel of the Company, with effect from the close of business hours on 12th August, 2026, due to his pre-occupation and other personal commitments. The Board placed on record its appreciation for the contribution and services rendered by Mr. Kunjan Nathabhai Rathod during his tenure with the Company. 3. Appointment of Mrs. Archana Chaitanya Pandya as Additional Director in the capacity of Whole- Time Director and Chief Financial Officer The Board considered and approved the appointment of Mrs. Archana Chaitanya Pandya (DIN: 10147795) as an Additional Director in the capacity of Whole-Time Director and Chief Financial Officer (Key Managerial Personnel) of the Company with effect from 14th August, 2026, subject to the approval of the shareholders of the Company, as applicable. BOSTON COMMERCE LIMITED (Formerly known as Boston Bio Systems Limited) Registered office: Office No. 11, Krishna Complex, Mahatma Gandhi Bridge, Shreyas Colony, Navrangpura, Ahmedabad, 380009 CIN: L62013GJ1995PLC025476; E-mail: bostonsystem@yahoo.com Website: www.bostonbio.in The requisite disclosures pursuant to Regulation 30 of the SEBI Listing Regulations read with the applicable SEBI Circulars are enclosed herewith as Annexure-I. 4. Resignation of Secretarial Auditor The Board took note of the resignation tendered by M/s Shashank Kumar & Associates, Practising Company Secretaries (FRN: S2018UP715500), from the position of Secretarial Auditor of the Company, with effect from 2nd July, 2026, due to pre-occupational reasons. The requisite disclosures pursuant to Regulation 30 of the SEBI Listing Regulations read with the applicable SEBI Circulars, along with the resignation letter received from the Secretarial Auditor, are enclosed herewith as Annexure-II. 5. Authorisation of Mrs. Archana Chaitanya Pandya for Bank Accounts The Board considered and approved the authorisation of Mrs. Archana Chaitanya Pandya (DIN: 10147795), Whole-Time Director and Chief Financial Officer, as an Authorised Signatory of the Company in respect of the existing bank account(s) and any new bank account(s) to be opened by the Company, and authorised her to sign, execute and submit such forms, applications, declarations, instructions, cheques, documents and other writings as may be required for operating and managing the bank accounts of the Company, in accordance with the authority granted by the Board. 6. Authorisation of Mrs. Archana Chaitanya Pandya for Statutory and Regulatory Filings The Board considered and approved the authorisation of Mrs. Archana Chaitanya Pandya (DIN: 10147795), Whole-Time Director and Chief Financial Officer, to sign, execute, submit and file, whether digitally or otherwise, forms, returns, applications, disclosures, intimations, documents, correspondence and other filings on behalf of the Company with the Ministry of Corporate Affairs, Registrar of Companies, BSE Limited and such other statutory, regulatory or governmental authorities, as may be applicable, in accordance with the authority granted by the Board and applicable law. 7. Reconstitution of Audit Committee Consequent upon the change in the composition of the Board of Directors and management of the Company, the Board considered and approved the reconstitution of the Audit Committee of the Company in accordance with Section 177 of the Companies Act, 2013 and Regulation 18 of the SEBI Listing Regulations, with effect from 14th August, 2026, as under: Sr. No Name Category Position in Committee 1. Ms. Jansi Falgunkumar Patel Non-Executive Independent Chairperson Director 2. Ms. Gunjan Jyotishbhai Leuva Non-Executive Independent Member Director BOSTON COMMERCE LIMITED (Formerly known as Boston Bio Systems Limited) Registered office: Office No. 11, Krishna Complex, Mahatma Gandhi Bridge, Shreyas Colony, Navrangpura, Ahmedabad, 380009 CIN: L62013GJ1995PLC025476; E-mail: bostonsystem@yahoo.com Website: www.bostonbio.in 3. Archana Chaitanya Pandya Whole-Time Director and Member Chief Financial Officer 8. Reconstitution of Nomination and Remuneration Committee Consequent upon the change in the composition of the Board of Directors and management of the Company, the Board considered and approved the reconstitution of the Nomination and Remuneration Committee of the Company in accordance with Section 178 of the Companies Act, 2013 and Regulation 19 of the SEBI Listing Regulations, with effect from 14th August, 2026, as under: Sr. No Name Category Position in Committee 1. Ms. Gunjan Jyotishbhai Leuva Non-Executive Independent Chairperson Director 2. Ms. Jansi Falgunkumar Patel Non-Executive Independent Member Director 3. Archana Chaitanya Pandya Whole-Time Director and Member Chief Financial Officer 9. Postponement of Board Meeting for Consideration of Unaudited Financial Results for the Quarter Ended 30th June, 2026 The Board was informed that the Unaudited Financial Results of the Company for the quarter ended 30th June, 2026, which were scheduled to be considered and approved at the Board Meeting, could not be finalised due to unavoidable circumstances and pending completion of certain financial and accounting matters. Accordingly, it has been decided to postpone the Board Meeting scheduled for consideration and approval of the said Unaudited Financial Results to Friday, 21st August, 2026. The Unaudited Financial Results for the quarter ended 30th June, 2026 shall accordingly be considered and approved at the postponed Board Meeting scheduled to be held on Friday, 21st August, 2026, and the necessary intimation in this regard shall be submitted to the Stock Exchange in accordance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 3:00 P.M. and concluded at 3:30 P.M. BOSTON COMMERCE LIMITED (Formerly known as Boston Bio Systems Limited) Registered office: Office No. 11, Krishna Complex, Mahatma Gandhi Bridge, Shreyas Colony, Navrangpura, Ahmedabad, 380009 CIN: L62013GJ1995PLC025476; E-mail: bostonsystem@yahoo.com Website: www.bostonbio.in You are requested to kindly take the above information on record. Thanking you, Yours faithfully, For Boston Commerce Limited ARCHANA CHAITANYA PANDYA ADDITIONAL WHOLE-TIME DIRECTOR DIN: 10147795 BOSTON COMMERCE LIMITED (Formerly known as Boston Bio Systems Limited) Registered office: Office No. 11, Krishna Co [Showing first 8,000 characters — download PDF for full document]